The story of GARP: a potential target for cancer immunotherapy
Colorectal cancer is the third leading cause of cancer-related deaths in both men and women. Despite significant advances in therapies […]
» Read moreA new CAMH study shows for the first time that people experiencing clinical depression have higher levels of a brain […] People who inherit a faulty copy of the so-called “breast cancer genes” BRCA1 and BRCA2 are at high risk of […] Target continues to make a bolder statement in the natural beauty space. Later this month, Target will add Grace + […] Kristin Ess is on her way to building a hair product empire. The celebrity hairstylist launched her namesake brand, Kristin […] The human brain is rich in lipids. Investigators studying Parkinson’s disease (PD) have become increasingly interested in lipids since both […] An experimental drug may be effective against a deadly form of pancreatic cancer when used in combination with other immune-boosting […] Walgreens continues to expand its skin-care offering, especially as the category is one of the bright spots in mass retailing. […] When alcohol enters the brain, it causes neurons in a specialized region called the ventral tegmental area, or VTA—also known […] About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2. These cancers do […]
Study reveals a new target for developing treatments for depression
Drug target identified for chemotherapy-resistant ovarian, breast cancer
Target Adds Grace + Tonic to Its Growing Natural Stable
Kristin Ess Is Building a $100 Million Hair Product Empire
New Parkinson’s disease drug target revealed through study of fatty acids
RIP1 Kinase identified as promising therapeutic target in pancreatic cancer
Walgreens Digs Deeper Into Skin Care
Researchers uncover new target of alcohol in the brain
Immune cells in triple-negative breast cancer offer potential therapeutic target
